CHAL 22 |
| The pharmaceutical industry facilitates the collision of intellectual property with antitrust. Furthermore, technology licensing arrangements raise complex legal issues. This presentation will review key issues in this industry and provide a broad based anaylsis of the how regulatory agencies effect a company's patent portfolio and antitrust guidelines. |
|
Pharmaceutical Companies Dealing with The Intersection of Patents and Anti-Trust Issues
10:00 AM-12:00 PM, Tuesday, April 8, 2008 Morial Convention Center -- Rm. 243, Oral
Division of Chemistry & the Law |